Complement localization and mediation of ischemic injury in baboon myocardium

The Journal of Clinical Investigation
R N PinckardM S Olson


We sought to determine whether the third component of complement (C3) is localized in ischemic baboon myocardium after coronary artery ligation. Furthermore, we assessed the effects of prior C3 depletion on myocardial necrosis. We studied seven control baboons (group I) and seven C3-depleted (group II) baboons that were killed 24 h after ligation of the anterior descending coronary artery. Multiple tissue samples were obtained from infarct, intermediate, and normal myocardial sites as defined by serial unipolar epicardial ECG mapping. In group I baboons, myocardial creatine kinase content from infarct sites was reduced as compared with normal sites (12.6+/-0.92 [SE] vs. 24.4+/-0.75 IU/mg protein, P < 0.001). The intermediate sites from group I contained more creatine kinase (19.0+/-1.25 IU/mg protein) than infarct sites (P < 0.001), but less (P < 0.025) than normal sites. In group II, intermediate sites showed no significant reduction in creatine kinase from normal sites and there was significantly less creatine kinase depletion in infarct sites when compared with group I animals (33.7+/-4.6 and 51.4+/-1.8% depletion, respectively, P < 0.001). In all seven group I baboons, uniform C3 localization was observed in infarct sites b...Continue Reading


Jul 1, 1977·The American Journal of Cardiology·R P Holland, H Brooks
Mar 1, 1978·The Journal of Clinical Investigation·D MacleanP R Maroko
Mar 1, 1978·The Journal of Clinical Investigation·P R MarokoS L Hale
Oct 1, 1976·Circulation·H A Fozzard, D S DasGupta
Nov 1, 1973·Annals of Internal Medicine·P R Maroko, E Braunwald
Jul 1, 1970·The Journal of Immunology : Official Journal of the American Association of Immunologists·C G CochraneB S Aikin
Apr 1, 1971·The Journal of Experimental Medicine·J H Hill, P A Ward
Jul 15, 1971·The New England Journal of Medicine·D L PageC A Sanders

❮ Previous
Next ❯


Jan 1, 1989·Cardiovascular Drugs and Therapy·S W Werns, B R Lucchesi
Apr 1, 1997·Virchows Archiv : an International Journal of Pathology·T TadaT Eimoto
Jan 1, 1987·Basic Research in Cardiology·G J Grover, H R Weiss
May 1, 1985·Basic Research in Cardiology·S R JollyB R Lucchesi
Aug 1, 1995·Immunopharmacology·M GardinaliA Agostoni
Jan 1, 1985·Journal of Free Radicals in Biology & Medicine·S W WernsB R Lucchesi
Mar 4, 2000·Molecular Immunology·C D CollardG L Stahl
Sep 1, 1987·Journal of the American College of Cardiology·W R BennettR Bolli
May 23, 2001·International Immunopharmacology·R NijmeijerC E Hack
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·U H del BalzoM J Polley
Dec 1, 1981·The Journal of Experimental Medicine·G BieseckerD Koffler
Dec 22, 1999·The Journal of Experimental Medicine·M GriselliM B Pepys
Aug 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A PachaïI Brandslund
Mar 3, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A Väkevä, S Meri
Sep 15, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Marc N BuscheGregory L Stahl
Aug 1, 1989·The Journal of Clinical Investigation·P S Seifert, G K Hansson
Aug 1, 1989·The Journal of Clinical Investigation·M K Hostetter, G M Johnson
Jan 1, 2009·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Laura R La BontePaul F McDonagh
Aug 27, 2009·Biologics : Targets & Therapy·Prathit A Kulkarni, Vahid Afshar-Kharghan
Oct 3, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·S K Shernan, C D Collard
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Chris de ZwaanWim Th Hermens
Oct 21, 2003·QJM : Monthly Journal of the Association of Physicians·G M Hirschfield, M B Pepys
Jul 11, 2008·Expert Opinion on Biological Therapy·Diana WoutersSacha Zeerleder
Mar 1, 1995·Kidney International·A VäkeväP Laurila
Dec 9, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James E FildesNizar Yonan
Apr 20, 2007·Biochimica Et Biophysica Acta·Cecilia L BasiglioAldo D Mottino
Oct 1, 2008·Journal of Internal Medicine·J P CasasM B Pepys

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.